Literature DB >> 19178061

Common pigmentation disorders.

Scott Plensdorf1, Joy Martinez.   

Abstract

Common causes of hyperpigmentation include postinflammatory hyperpigmentation, melasma, solar lentigines, ephelides (freckles), and café-au-lait macules. Although most hyperpigmented lesions are benign and the diagnosis is straightforward, it is important to exclude melanoma and its precursors and to identify skin manifestations of systemic disease. Treatment options for postinflammatory hyperpigmentation, melasma, solar lentigines, and ephelides include the use of topical agents, chemical peels, cryotherapy, or laser therapy. Caf&-au-lait macules are amenable to surgical excision or laser treatment. Disorders of hypopigmentation may also pose diagnostic challenges, although those associated with health risks are uncommon and are usually congenital (e.g., albinism, piebaldism, tuberous sclerosis, hypomelanosis of Ito). Acquired disorders may include vitiligo, pityriasis alba, tinea versicolor, and postinflammatory hypopigmentation. Treatment of patients with widespread or generalized vitiligo may include cosmetic coverage, psoralen ultraviolet A-range therapy (with or without psoralens), or narrow-band ultraviolet-B therapy; whereas those with stable, limited disease may be candidates for surgical grafting techniques. Patients with extensive disease may be candidates for depigmentation therapy. Other acquired disorders may improve or resolve with treatment of the underlying condition.

Entities:  

Mesh:

Year:  2009        PMID: 19178061

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  10 in total

1.  Analysis of blood and lymph vascularization patterns in tissue-engineered human dermo-epidermal skin analogs of different pigmentation.

Authors:  Agnieszka S Klar; Sophie Böttcher-Haberzeth; Thomas Biedermann; Clemens Schiestl; Ernst Reichmann; Martin Meuli
Journal:  Pediatr Surg Int       Date:  2014-02       Impact factor: 1.827

2.  Chemical leukoderma after the application of a transdermal methylphenidate patch.

Authors:  Pedram Ghasri; Shilpa Gattu; Naz Saedi; Anand K Ganesan
Journal:  J Am Acad Dermatol       Date:  2012-06       Impact factor: 11.527

3.  Micropore Closure Rates following Microneedle Application at Various Anatomical Sites in Healthy Human Subjects.

Authors:  Abayomi Tolulope Ogunjimi; Christine Lawson; Jamie Carr; Krishna Kumar Patel; Nkanyezi Ferguson; Nicole K Brogden
Journal:  Skin Pharmacol Physiol       Date:  2021-04-28       Impact factor: 3.479

4.  Involvement of Transient Receptor Potential Cation Channel Member A1 activation in the irritation and pain response elicited by skin-lightening reagent hydroquinone.

Authors:  Yan Tai; Chuan Wang; Zhihua Wang; Yi Liang; Junying Du; Dongwei He; Xiaoyan Fan; Sven-Eric Jordt; Boyi Liu
Journal:  Sci Rep       Date:  2017-08-08       Impact factor: 4.379

Review 5.  Modulating skin colour: role of the thioredoxin and glutathione systems in regulating melanogenesis.

Authors:  Yaoying Lu; Kathryn F Tonissen; Giovanna Di Trapani
Journal:  Biosci Rep       Date:  2021-05-28       Impact factor: 3.840

6.  A systematic exploration reveals the potential of spermidine for hypopigmentation treatment through the stabilization of melanogenesis-associated proteins.

Authors:  Sofia Brito; Hyojin Heo; Byungsun Cha; Su-Hyun Lee; Sehyun Chae; Mi-Gi Lee; Byeong-Mun Kwak; Bum-Ho Bin
Journal:  Sci Rep       Date:  2022-08-25       Impact factor: 4.996

7.  Azastilbene analogs as tyrosinase inhibitors: new molecules with depigmenting potential.

Authors:  Larissa Lavorato Lima; Rebeca Mól Lima; Annelisa Farah da Silva; Antônio Márcio Resende do Carmo; Adilson David da Silva; Nádia Rezende Barbosa Raposo
Journal:  ScientificWorldJournal       Date:  2013-02-12

Review 8.  Mechanisms regulating melanogenesis.

Authors:  Inês Ferreira dos Santos Videira; Daniel Filipe Lima Moura; Sofia Magina
Journal:  An Bras Dermatol       Date:  2013 Jan-Feb       Impact factor: 1.896

9.  Involvement of Transglutaminase-2 in α-MSH-Induced Melanogenesis in SK-MEL-2 Human Melanoma Cells.

Authors:  Hyun Ji Kim; Hye Ja Lee; Mi Kyung Park; Kyung Jin Gang; Hyun Jung Byun; Jeong Ho Park; Mi Kyung Kim; Soo Youl Kim; Chang Hoon Lee
Journal:  Biomol Ther (Seoul)       Date:  2014-05       Impact factor: 4.634

10.  Inhibitory effects of resveratrol analogs on mushroom tyrosinase activity.

Authors:  Danielle Cristina Zimmermann Franco; Gustavo Senra Gonçalves de Carvalho; Paula Rafaela Rocha; Raquel da Silva Teixeira; Adilson David da Silva; Nádia Rezende Barbosa Raposo
Journal:  Molecules       Date:  2012-10-09       Impact factor: 4.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.